Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-393-6 | CAS number: 95-13-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 Aug 2005 - 01 Sep 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21st July 1997
- Deviations:
- yes
- Remarks:
- See "Principles of method other than guideline"
- Qualifier:
- according to guideline
- Guideline:
- other: Testing Methods for New Chemical Substances etc. (Yakushokuhatsu No. 1121002, 21st November 2003; Seikyoku No.2, 13th November, 2003; Kampo Kihatsu No. 031121002)
- Version / remarks:
- 2003
- Deviations:
- no
- Principles of method if other than guideline:
- Deviations:
OECD guide 471 line states that "2-Aminoanthracene should not be used as the sole indicator of the efficacy of the S9-mix. If 2-
aminoanthracene is used, each batch of S9 should also be characterised with a mutagen that requires
metabolic activation by microsomal enzymes, e.g., benzo(a)pyrene, dimethylbenzanthracene." In the study 2-Aminoanthracene was used as a sole indicitaor for the efficacy of the S9-mix, but the batch of S9 was not reported to have been further characterised with a mutagen that requires metabolic activation.
However, since a significant increase in revertants was seen for all strains, the deviation is not considered to affect the study integrity.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Indene
- EC Number:
- 202-393-6
- EC Name:
- Indene
- Cas Number:
- 95-13-6
- Molecular formula:
- C9H8
- IUPAC Name:
- indene
- Test material form:
- liquid
- Details on test material:
- Identification: Indene
Constituent 1
Method
- Target gene:
- - S. typhimurium: Histidine gene
- E. coli: Tryptophan gene
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9-mix induced by a combination of phenobarbital and 5,6-Benzoflavone
- Test concentrations with justification for top dose:
- Experiment 1: Dose finding study
Preliminary test (without and with S9): TA1535, TA1537, TA98 TA100 and WP2uvrA: 8.19, 20.5, 51.2 , 128, 320, 800, 2000 and 5000 µg/plate
Main study: TA1535, TA1537, TA98 TA100 and WP2uvrA
Without and with S9-mix: 6.25, 12.5, 25.0, 50.0, 100, 200, 400 µg/plate
The highest concentration in the main study was chosen to be 400 µg/plate as in the dose finding study bacterial growth was inhibited at 320 µg/plate. - Vehicle / solvent:
- - solvent used: DMSO
- Justification for choice of solvent:
The test substance is easily soluble in DMSO and DMSO is accepted and approved by authorities and international guidelines
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-(2-Furyl)-3-(5-nitro-2-furyl) acrylamide
- Remarks:
- without S9 0.01 ug/plate for TA100 in DMSO for TA100
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-(2-Furyl)-3-(5-nitro-2-furyl) acrylamide
- Remarks:
- Without S9 0.1 ug/plate in DMSO for TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without S9 80 ug/plate in DMSO for TA 1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- without S9 , 0.5 µg/plate in water for TA1535
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-(2-Furyl)-3-(5-nitro-2-furyl) acrylamide
- Remarks:
- without S9 0.1 µg/plate in DMSO for WP2uvrA
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene in DMSO for all tester strains
- Remarks:
- with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 hour
NUMBER OF REPLICATIONS:
- Doses of the test substance were tested in triplicate in each strain.
- One dose finding study and one main study were performed.
NUMBER OF CELLS EVALUATED:
100uL of stock solution added on plate, approx 1-4x10E8 cells.
OTHER EXAMINATIONS:
- Microbial growth inhibtion was determined
- The presence of precipitation of the test compound on the plates was determined. - Evaluation criteria:
- The experimental results were judged positive when the number of revertant colonies was twice or more that of the negative control and showed a dose-relationship or reproducibility.
- Statistics:
- A statistical analysis was not used for evaluation.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation in dose finding assay: At the start of treatment, white turbid medium was observed at 800 ug/plate or more dose levels in presence and absence of S9 mix. In addition, white oil droplet-like precipitations were observed at 5000 ug/plate in absence of S9 mix and white powder-like precipitations were observed at 2000 ug/plate or more levels in presence of S9 mix.
At the colony counting, white powder-like precipitations were observed at 800 ug/plate or more dose levels in presence of S9 mix.
RANGE-FINDING/SCREENING STUDIES:
- Microbial growth inhibition was found at 320 µg/plate
COMPARISON WITH HISTORICAL CONTROL DATA:
- The mean number of revertant colonies in both the negative and positive controls were within the ranges based on the historical data as included in the report.
Applicant's summary and conclusion
- Conclusions:
- In an AMES test, performed according to OECD guideline 471 and GLP principles, Indene was found not to be mutagenic with or without metabolic activation.
- Executive summary:
An AMES test was performed according to OECD guideline 471 and GLP principles. All bacterial strains showed negative responses up to and at the dose that inhibited bacterial growth (320 ug/plate), i.e. no significant dose-related increase in the number of revertants with or without metabolic activation was seen. Precipitation of the test substance was observed in dose levels above 800 ug/plate. The negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Indene is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay with or without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)